148 related articles for article (PubMed ID: 11561690)
1. Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group phase II study.
Samlowski WE; Gundacker H; Kuebler JP; Giguere JK; Mills GM; Schuller DE; Ensley JF
Invest New Drugs; 2001; 19(4):311-5. PubMed ID: 11561690
[TBL] [Abstract][Full Text] [Related]
2. A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.
Catimel G; Vermorken JB; Clavel M; de Mulder P; Judson I; Sessa C; Piccart M; Bruntsch U; Verweij J; Wanders J
Ann Oncol; 1994 Jul; 5(6):543-7. PubMed ID: 7918127
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine in the treatment of advanced head and neck cancer.
Raguse JD; Gath HJ; Bier J; Riess H; Oettle H
Clin Oncol (R Coll Radiol); 2005 Sep; 17(6):425-9. PubMed ID: 16149285
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group study.
Samlowski WE; Lew D; Kuebler PJ; Kolodziej MA; Medina JE; Mangan KF; Moore DF; Schuller DE; Ensley JF
Invest New Drugs; 1998-1999; 16(3):271-4. PubMed ID: 10360608
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck.
Hitt R; Castellano D; Hidalgo M; García-Carbonero R; Peña M; Brandariz A; Millán JM; Alvarez Vincent JJ; Cortés-Funes H
Ann Oncol; 1998 Dec; 9(12):1347-9. PubMed ID: 9932167
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck.
Aguilar-Ponce J; Granados-García M; Villavicencio V; Poitevin-Chacón A; Green D; Dueñas-González A; Herrera-Gómez A; Luna-Ortiz K; Alvarado A; Martínez-Said H; Castillo-Henkel C; Segura-Pacheco B; De la Garza J
Ann Oncol; 2004 Feb; 15(2):301-6. PubMed ID: 14760126
[TBL] [Abstract][Full Text] [Related]
7. A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer.
Manegold C; Drings P; von Pawel J; Ricci S; Dornoff W; van Walree N; ten Bokkel Huinink W; Chemaissani A; Stahel P; Bergman B; Wagenius G; Sederholm C; Mattson K; Liippo K; Kellokumpu-Lehtinen P
Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-13-S8-17. PubMed ID: 9207310
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group.
Schöffski P; Catimel G; Planting AS; Droz JP; Verweij J; Schrijvers D; Gras L; Schrijvers A; Wanders J; Hanauske AR
Ann Oncol; 1999 Jan; 10(1):119-22. PubMed ID: 10076732
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction.
Sandler AB; Kindler HL; Einhorn LH; Mitchell E; Masters G; Kraut M; Nicol S; Raghavan D
Ann Oncol; 2000 Sep; 11(9):1161-4. PubMed ID: 11061612
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group.
Fountzilas G; Stathopoulos G; Nicolaides C; Kalogera-Fountzila A; Kalofonos H; Nikolaou A; Bacoyiannis C; Samantas E; Papadimitriou C; Kosmidis P; Daniilidis J; Pavlidis N
Ann Oncol; 1999 Apr; 10(4):475-8. PubMed ID: 10370793
[TBL] [Abstract][Full Text] [Related]
11. Phase II studies of gemcitabine for non-small cell lung cancer in Japan.
Fukuoka M; Takada M; Yokoyama A; Kurita Y; Niitani H
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-42-S7-46. PubMed ID: 9194479
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine and paclitaxel in metastatic or recurrent squamous cell carcinoma of the head and neck: a phase I-II study.
Stier S; Koll C; Neuhaus T; Fronhoffs S; Forkert R; Tuohimaa A; Vetter H; Ko Y
Anticancer Drugs; 2005 Nov; 16(10):1115-21. PubMed ID: 16222154
[TBL] [Abstract][Full Text] [Related]
13. Promising overall survival of patients with recurrent/metastatic squamous cell carcinoma of head and neck receiving gemcitabine plus cisplatin treatment: report of a multi-center phase II study.
Yang MH; Chang PM; Tzeng CH; Chang SY; Chu PY; Tai SK; Tsai TL; Wang YF; Huang JL; Wang HM; Chen PM
Cancer Chemother Pharmacol; 2010 Jan; 65(2):259-65. PubMed ID: 19466409
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.
Shepherd FA; Cormier Y; Burkes R; Evans WK; Goss G; Klimo P; Feld R; Taylor M
Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-27-S8-30. PubMed ID: 9207313
[TBL] [Abstract][Full Text] [Related]
15. Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982).
van Herpen CM; Locati LD; Buter J; Thomas J; Bogaerts J; Lacombe D; de Mulder P; Awada A; Licitra L; Bernier J; Vermorken JB
Eur J Cancer; 2008 Nov; 44(17):2542-5. PubMed ID: 18819792
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of single-agent gemcitabine in advanced non-small cell lung cancer: a review.
Hansen HH; Sørensen JB
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-38-S7-41. PubMed ID: 9194478
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
Schilder RJ; Blessing J; Cohn DE
Gynecol Oncol; 2005 Jan; 96(1):103-7. PubMed ID: 15589587
[TBL] [Abstract][Full Text] [Related]
18. A phase II trial of gemcitabine in the treatment of advanced bile duct and periampullary carcinomas.
Lin MH; Chen JS; Chen HH; Su WC
Chemotherapy; 2003 Jun; 49(3):154-8. PubMed ID: 12815209
[TBL] [Abstract][Full Text] [Related]
19. Single-agent gemcitabine in non-small cell lung cancer: the French experience.
Le Chevalier T; Gottfried M
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-47-S7-49. PubMed ID: 9194480
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group.
Schilder RJ; Blessing JA; Morgan M; Mangan CE; Rader JS
Gynecol Oncol; 2000 Feb; 76(2):204-7. PubMed ID: 10637071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
